제이피아이헬스케어
Financials
Valuation Metrics
제이피아이헬스케어's Market Cap is ₩443B. Ranked #1852 of 2,421 in KR market (top 76%), #1141 of 1,640 on KOSDAQ (top 70%), #195 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 84%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 44.26B KRW | KR#1,852/2,421 Sec#195/231 |
| Revenue | 48.47B KRW | KR#1,812/2,421 Sec#125/231 |
| Net Income | 4.84B KRW | KR#1,227/2,421 Sec#84/231 |
| Total Assets | 82.38B KRW | KR#1,921/2,421 Sec#157/231 |
| Net Assets | 63.05B KRW | KR#1,756/2,421 Sec#147/231 |
| Value | ||
| P/E | 9.14x | KR#750/2,421 Sec#37/231 |
| P/B | 0.70x | KR#1,124/2,421 Sec#62/231 |
| P/S | 0.91x | KR#1,326/2,421 Sec#77/231 |
| EV/EBITDA | 9.85x | KR#607/2,421 Sec#27/231 |
| FCF Yield | 4.71% | KR#866/2,421 Sec#46/231 |
| Profitability | ||
| ROE | 7.68% | KR#822/2,421 Sec#56/231 |
| ROA | 5.88% | KR#636/2,421 Sec#51/231 |
| Op. Margin | 10.03% | KR#519/2,421 Sec#45/231 |
| Financial Health | ||
| Debt Ratio | 30.65% | KR#605/2,421 Sec#71/231 |
| Total Debt | 10.98B KRW | KR#1,592/2,421 Sec#142/231 |
| FCF | 2.09B KRW | KR#1,080/2,421 Sec#76/231 |
| Cash | 7.36B KRW | KR#1,853/2,421 Sec#164/231 |
| Current Ratio | 7.52x | KR#160/2,421 Sec#35/231 |
| Net Debt/EBITDA | 0.74x | KR#705/2,421 Sec#45/231 |
| Dividend | ||
| Div. Yield | 2.86% | KR#670/2,421 Sec#34/231 |
| Performance | ||
| 1Y Return | -52.31% | KR#2,091/2,421 Sec#192/231 |
| 1M Return | -6.57% | KR#1,906/2,421 Sec#155/231 |
| From 52W High | -65.32% | KR#2,047/2,421 Sec#167/231 |
| 1Y MDD | -69.21% | KR#1,961/2,421 Sec#168/231 |
| Trading | ||
| Volume | 1,504 shares | KR#2,294/2,421 Sec#218/231 |
| Trading Value | 13.0M KRW | KR#2,234/2,421 Sec#215/231 |
| Foreign Own. | 0.98% | KR#2,047/2,421 Sec#199/231 |
| Per Share | ||
| EPS | 948 KRW | KR#741/2,421 Sec#51/231 |
| BPS | 12,350 KRW | KR#832/2,421 Sec#57/231 |
Company Info
JPI Healthcare, a small and medium-sized venture company established in 1980 and renamed in 2010, specializes in the development and manufacturing of X-ray-based imaging diagnostic core components, including grids and various imaging devices. The company produces and sells next-generation medical imaging equipment such as digital X-ray medical imaging devices, digital tomosynthesis, and mobile low-dose, high-precision CT systems. Its products are supplied to over 300 global companies, including GE, Siemens, and Philips. JPI Healthcare is headquartered in Guro-gu, Seoul Metropolitan City.